High-dose chemotherapy followed by autologous stem cell transplantation changes prognosis of IgD multiple myeloma.

• Authors: MAISNAR Vladimír; HÁJEK Roman; ŠČUDLA Vlastimil; GREGORA Evžen; BÜCHLER Tomáš; TICHÝ Miloš; KOTOUČEK Pavol; KAFKOVÁ Adriana; FORRAIOVÁ Lubica; MINAŘÍK Jiří; RADOCHA Jakub; BLÁHA V.; MALÝ Jaroslav
• Year of publication: 2008
• Type: Article in Periodical
• Magazine / Source: Bone Marrow Transplantation
• MU Faculty or unit: Faculty of Medicine
• Field: Oncology and hematology
• Keywords: multiple myeloma;stem cell; autologous translantation; high-dose chemotherapy
• Description: Immunoglobulin D (IgD) multiple myeloma (MM) is a rare plasma cell disorder constituting less than 2% of all MM cases. Survival of patients with IgD MM is generally shorter than that of patients with other types of monoclonal (M-) protein. We have retrospectively analyzed patients with IgD MM participating in clinical trials of the Czech Myeloma Group.